مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.
Normal view MARC view ISBD view

Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. [electronic resource]

By:
  • Cuellar, Sandra
Contributor(s):
  • McBride, Ali
  • Medina, Patrick
Producer: 20200302Description: 1725-1738 p. digitalISSN:
  • 1535-2900
Subject(s):
  • Antineoplastic Agents, Immunological -- therapeutic use
  • Bevacizumab -- therapeutic use
  • Biosimilar Pharmaceuticals -- therapeutic use
  • Drug Approval -- legislation & jurisprudence
  • Drug Development -- legislation & jurisprudence
  • Humans
  • Medical Oncology -- methods
  • Molecular Targeted Therapy -- methods
  • Neoplasms -- drug therapy
  • Pharmacists -- organization & administration
  • Pharmacy and Therapeutics Committee -- legislation & jurisprudence
  • Rituximab -- therapeutic use
  • Trastuzumab -- therapeutic use
  • United States
  • United States Food and Drug Administration -- legislation & jurisprudence
Online resources:
  • Available from publisher's website
In: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists vol. 76
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

Log in to your account to post a comment.
Browse results Close
Previous
Back to results
Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 1 How to recognize an unwillng kidney donor.
    by Al-Khader, A A
  • 2 Kaposi's sarcoma in renal transplant recipients.
    by al-Sulaiman, M H
  • 3 Living non-related kidney transplantation in Bombay.
    by al-Khader, A A
  • 4 FK 506 as an alternative in cyclosporin-induced hemolytic uremic syndrome in a kidney transplant recipient.
    by Abdalla, A H
  • 5 Successful use of rifampicin in the treatment of tuberculosis in renal transplant patients immunosuppressed with cyclosporine.
    by al-Sulaiman, M H
  • 6 Long-term nephrotoxicity after exposure to cyclosporine in utero.
    by Shaheen, F A
  • 7 The role of androgen receptor gene in cyclosporine induced gingival overgrowth.
    by Al Sayed, A A
  • 8 Effect of lithium on cyclosporin induced nephrotoxicity in rats.
    by Tariq, M
  • 9 N-acetylcysteine attenuates cyclosporin-induced nephrotoxicity in rats.
    by Tariq, M
  • 10 Post renal transplantation non-Hodgkin's lymphoma: Local experience and review of the literature.
    by Boubenider, S A
  • 11 Quinacrine attenuates cyclosporine-induced nephrotoxicity in rats.
    by al Khader, A
  • 12 Renal transplantation from HBsAg positive donors to HBsAg negative recipients.
    by al-Khader, A A
  • 13 Kaposi's sarcoma in renal transplant recipients.
    by Shaheen, F A
  • 14 Does regressed posttransplantation Kaposi's sarcoma recur following reintroduction of immunosuppression?
    by al-Sulaiman, M H
  • 15 Influence of sex and chronic haemodialysis treatment on total, free and acyl carnitine concentrations in human serum.
    by Alhomida, A S
  • 16 Some of the Lessons Learnt from Renal Transplant Recipients Cared-for at the Riyadh Armed Forces Hospital.
    by Al-Khader, A A
  • 17 Recurrent allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome.
    by Rassoul, Z
  • 18 Impact of HIV infection on dialysis and renal transplantation.
    by al-Sulaiman, M
  • 19 Aluminum exacerbates cyclosporin induced nephrotoxicity in rats.
    by Tariq, M
  • 20 Non-typhoid Salmonella in renal transplant recipients: a report of twenty cases and review of the literature.
    by Dhar, J M
Close

Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice.

APA

Cuellar S., McBride A. & Medina P. (20200302). Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. : American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Chicago

Cuellar Sandra, McBride Ali and Medina Patrick. 20200302. Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. : American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Harvard

Cuellar S., McBride A. and Medina P. (20200302). Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. : American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

MLA

Cuellar Sandra, McBride Ali and Medina Patrick. Pharmacist perspectives and considerations for implementation of therapeutic oncology biosimilars in practice. : American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 20200302.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site